ArticleRwanda journal of medicine and health sciences2025
Thyroid Function Test Abnormalities in Human Immunodeficiency Virus Positive Patients on Antiretroviral Therapy at Matyazo Health Center, Huye, Rwanda.
Article in Rwanda journal of medicine and health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thyroid dysfunction (TD) is commonly found in people living with HIV infection (PLHIV) and is exacerbated by ART. While TD is documented in PLHIV, its prevalence in Rwanda remains underexplored. This study investigated thyroid dysfunction in HIV-positive patients on ART at Matyazo Health Centre, Butare, Rwanda. The study aimed to assess the prevalence and distribution of thyroid function test (TFT) abnormalities among HIV-positive individuals receiving antiretroviral therapy (ART) at Matyazo Health Centre, Rwanda. Methods: A cross-sectional study involving 200 participants (100 HIV-positive on ART and 100 HIV-negative controls, mainly healthcare workers and university students) was undertaken. Blood specimens were obtained for thyroid function assessments, including thyroid stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) when indicated. A standardised questionnaire captured sociodemographic information and clinical data were extracted from medical records. Results: Thyroid dysfunction prevalence was greater among HIV-positive participants compared to HIV-negative controls (47% vs. 16%). The predominant abnormality was central hypothyroidism/euthyroid sick syndrome (ESS), particularly in those on ART for over 24 months. Subclinical hyperthyroidism was less common. Educational attainment (p=0.006) and employment status (p=0.028) were significantly associated with thyroid dysfunction. Conclusion: The high prevalence of TD among HIV-positive patients on ART suggests an association between HIV infection, ART, and thyroid dysfunction, underscoring the importance of regular thyroid function screening. To build on these findings, longitudinal studies are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.